Exact Mass: 1254.593407

Exact Mass Matches: 1254.593407

Found 20 metabolites which its exact mass value is equals to given mass value 1254.593407, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dactinomycin

N1,N9-bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6,13-bis(propan-2-yl)-hexadecahydro-1H-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide

C62H86N12O16 (1254.6284436)

A compound composed of a two cyclic peptides attached to a phenoxazine that is derived from streptomyces parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DA - Actinomycines C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents

actinomycin D

2-amino-4,6-dimethyl-3-oxo-N1,N9-bis[2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6,13-bis(propan-2-yl)-hexadecahydro-1H-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-3H-phenoxazine-1,9-dicarboxamide

C62H86N12O16 (1254.6284436)

D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents

ARA290

4-{[3-carbamoyl-1-({1-[(1-{[1-({1-[(2-{[2-carbamoyl-1-({1-[(1-carboxy-2-hydroxyethyl)carbamoyl]-2-hydroxyethyl}carbamoyl)ethyl]amino}-5-methylhex-1-en-3-yl)carbamoyl]ethyl}carbamoyl)-4-[(diaminomethylidene)amino]butyl]carbamoyl}-3-carboxypropyl)carbamoyl]-3-methylbutyl}carbamoyl)propyl]carbamoyl}-4-[(5-oxopyrrolidin-2-yl)formamido]butanoic acid

C52H86N16O20 (1254.6203996)

Deapi-platycodin D3

deapio-platycodin D3

C58H94O29 (1254.5880474)

Deapio-platycodin D3 is a triterpenoid saponin. It has a role as a metabolite. Deapi-platycodin D3 is a natural product found in Platycodon grandiflorus with data available. A natural product found in Platycodon grandiflorum.

Platycoside A

C58H94O29 (1254.5880474)

luteophanol A

C60H102O25S (1254.6430562)

(S)-jalapinolic acid 11-O-alpha-L-rhamnopyranosyl-(1->3)-O-[3-O-trans-cinnamoyl-4-O-isobutanoyl-alpha-L-rhamnopyranosyl-(1->4)]-O-(2-O-butanoyl)-alpha-L-rhamnopyranosyl-(1->4)-O-alpha-L-rhamnopyranosyl-(1->2)-O-beta-D-fucopyranoside 1,3 ester|batatoside B

(S)-jalapinolic acid 11-O-alpha-L-rhamnopyranosyl-(1->3)-O-[3-O-trans-cinnamoyl-4-O-isobutanoyl-alpha-L-rhamnopyranosyl-(1->4)]-O-(2-O-butanoyl)-alpha-L-rhamnopyranosyl-(1->4)-O-alpha-L-rhamnopyranosyl-(1->2)-O-beta-D-fucopyranoside 1,3 ester|batatoside B

C63H98O25 (1254.6396858)

methylanagallosaponin

C59H98O28 (1254.6244308)

butyroside D

C57H90O30 (1254.551664)

2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide

NCGC00025059-05!2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide

C62H86N12O16 (1254.6284436)

actinomycin D

Actinomycin-[threo-val-pro-sar-meval]

C62H86N12O16 (1254.6284436)

Dactinomycin

actinomycin D

C62H86N12O16 (1254.6284436)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DA - Actinomycines C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents

Cosmegen

actinomycin D

C62H86N12O16 (1254.6284436)

deapio-platycodin D2

C58H94O29 (1254.5880474)

A natural product found in Platycodon grandiflorum.

2-Amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboxylic acid bis[1-[10,13-dimethyl-2,5,8,11,14-pentaoxo-3,9-di(propan-2-yl)-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-6-yl]ethyl] ester

C62H86N12O16 (1254.6284436)

(2s,3s,4s,5r,6r)-6-{[(2s,3r,4r,4as,5r,6ar,6bs,8r,8ar,12as,14ar,14br)-8a-({[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4s,5r,6s)-5-{[(2s,3r,4s,5r)-4-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4,5,6-trihydroxyoxan-2-yl]oxy}carbonyl)-2,5,8-trihydroxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-6-{[(2s,3r,4r,4as,5r,6ar,6bs,8r,8ar,12as,14ar,14br)-8a-({[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4s,5r,6s)-5-{[(2s,3r,4s,5r)-4-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4,5,6-trihydroxyoxan-2-yl]oxy}carbonyl)-2,5,8-trihydroxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C57H90O30 (1254.551664)

n1,n9-bis[(13r,18as)-11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboximidic acid

n1,n9-bis[(13r,18as)-11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboximidic acid

C62H86N12O16 (1254.6284436)

2-amino-n1-{11-hydroxy-13-isopropyl-2,5,6,9-tetramethyl-1,4,7,14,17-pentaoxo-3h,6h,9h,10h,13h,16h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl}-n9-{11-hydroxy-6,13-diisopropyl-2,5,9,16-tetramethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl}-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboximidic acid

2-amino-n1-{11-hydroxy-13-isopropyl-2,5,6,9-tetramethyl-1,4,7,14,17-pentaoxo-3h,6h,9h,10h,13h,16h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl}-n9-{11-hydroxy-6,13-diisopropyl-2,5,9,16-tetramethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl}-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboximidic acid

C61H82N12O17 (1254.5920602)

n-[(2r,3r,4s,6r)-6-{[(1s,5s,6r,9s,11e,13s,16s,17s,18s,20s,21r,22s)-17-{[(2r,4r,5s,6s)-5-(acetyloxy)-4-{[(2s,4r,5r,6s)-5-{[(2r,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5,23-dihydroxy-8,12,18,20,22-pentamethyl-25,27-dioxo-3-[(1e)-3-oxobut-1-en-1-yl]-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-3,7,11,14,23-pentaen-9-yl]oxy}-2,4-dimethyl-4-nitrooxan-3-yl]methoxycarboximidic acid

n-[(2r,3r,4s,6r)-6-{[(1s,5s,6r,9s,11e,13s,16s,17s,18s,20s,21r,22s)-17-{[(2r,4r,5s,6s)-5-(acetyloxy)-4-{[(2s,4r,5r,6s)-5-{[(2r,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5,23-dihydroxy-8,12,18,20,22-pentamethyl-25,27-dioxo-3-[(1e)-3-oxobut-1-en-1-yl]-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-3,7,11,14,23-pentaen-9-yl]oxy}-2,4-dimethyl-4-nitrooxan-3-yl]methoxycarboximidic acid

C64H90N2O23 (1254.593407)

(2r,3r,4s,5s,6r)-2-{[(3s,4r,4ar,6ar,6br,8s,8as,12bs,14ar,14br)-3,8-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-8a-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-4-yl]methoxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3s,4r,4ar,6ar,6br,8s,8as,12bs,14ar,14br)-3,8-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-8a-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-4-yl]methoxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C59H98O28 (1254.6244308)